Status: Not yet recruiting
Performance Study of the INSTI® and TruPlex Rapid Blood Typing Platforms
CLS-019A is a prospective, multi-site, parallel clinical performance study. Each enrolled subject is tested on both investigational devices in parallel within a single study visit, yielding paired INSTI® and TruPlex results from matched capillary fingerstick and EDTA-VWB samples.
Participants needed: 2,500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: bioLytical LaboratoriesUpdated: Aug 18, 2026
Eligibility criteria
Subject is 18 years of age or older at the time of enrollment. [+8]
Subject has known bleeding disorder or any other medical condition that, in the... [+6]